Pacira BioSciences
PCRX
PCRX
156 hedge funds and large institutions have $1.37B invested in Pacira BioSciences in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 54 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 168 → 156 (-12)
38% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 29
56% less call options, than puts
Call options by funds: $12.2M | Put options by funds: $27.6M
Holders
156
Holding in Top 10
4
Calls
$12.2M
Puts
$27.6M
Top Buyers
| 1 | +$45M | |
| 2 | +$35.9M | |
| 3 | +$24.6M | |
| 4 |
HM
HealthCor Management
New York
|
+$17.8M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$11.8M |
Top Sellers
| 1 | -$26M | |
| 2 | -$22.6M | |
| 3 | -$21.9M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$20.2M |
| 5 |
Jennison Associates
New York
|
-$16M |